XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Other Long-Term Liabilities
 3 Months Ended
Mar. 31, 2022
Other Liabilities Disclosure [Abstract]  
Other Long-Term Liabilities OTHER LONG-TERM LIABILITIES
(in millions)March 31,
2022		December 31,
2021
Contingent consideration$4.8 $5.4 
Other0.1 0.2 
Total other long-term liabilities$4.9 $5.6 
The Company's balance of other long-term liabilities as of March 31, 2022 and December 31, 2021 consists primarily of the long-term portion of contingent consideration related to the acquisition of Sividon Diagnostics.